Pesquisas alternativas:
losses derived » glasses derived (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), lobes derived (Expandir a Pesquisa)
dosage devel » dosage level (Expandir a Pesquisa), dosage levels (Expandir a Pesquisa), dosage reveals (Expandir a Pesquisa)
derived type » derived tgf (Expandir a Pesquisa), derived tnf (Expandir a Pesquisa)
drug losses » drag losses (Expandir a Pesquisa), drug classes (Expandir a Pesquisa), drug doses (Expandir a Pesquisa)
dose devel » dose level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa), dose novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
losses derived » glasses derived (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), lobes derived (Expandir a Pesquisa)
dosage devel » dosage level (Expandir a Pesquisa), dosage levels (Expandir a Pesquisa), dosage reveals (Expandir a Pesquisa)
derived type » derived tgf (Expandir a Pesquisa), derived tnf (Expandir a Pesquisa)
drug losses » drag losses (Expandir a Pesquisa), drug classes (Expandir a Pesquisa), drug doses (Expandir a Pesquisa)
dose devel » dose level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa), dose novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
101
Por Elzeny, Hadeel, Zhang, Fuwu, Ali, Esraa N, Fathi, Heba A, Zhang, Shiyi, Li, Richen, El-Mokhtar, Mohamed A, Hamad, Mostafa A, Wooley, Karen L, Elsabahy, Mahmoud
Publicado no Drug Des Devel Ther (2017)
“... of PPE nanoparticles of cationic and neutral surface charges for multiple delivery of anticancer drugs...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
102
Por Huang, Yuan, Liu, Nannan, Liu, Jing, Liu, Yeying, Zhang, Chuchu, Long, Shuaiyu, Luo, Guang, Zhang, Lingling, Zhang, Yingjie
Publicado no Cell Cycle (2019)
“...-derived growth factor; WT p53: wild-type p53 protein; mutp53: mutant p53 proteins; BAX: Bcl-2-associated X...”Publicado no Cell Cycle (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
103
Por Alicka, Michalina, Kornicka-Garbowska, Katarzyna, Kucharczyk, Katarzyna, Kępska, Martyna, Rӧcken, Michael, Marycz, Krzysztof
Publicado no Stem Cell Res Ther (2020)
“...BACKGROUND: Progressive loss of cell functionality caused by an age-related impairment in cell...”Publicado no Stem Cell Res Ther (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
104
“..., but the lack of clear distinction between the therapeutic and toxic doses was a major challenge...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
105
Por Gu, Namyi, Park, Min Kyu, Kim, Tae-Eun, Bahng, Mi Young, Lim, Kyoung Soo, Cho, Sang-Heon, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang
Publicado em 2014
“...) inhibitor in clinical development for the treatment of type 2 diabetes mellitus. This study aimed...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
106
Por Oh, Minkyung, Park, Sung-Eun, Ghim, Jong-Lyul, Choi, Young-Kyung, Shim, Eon-Jeong, Shin, Jae-Gook, Kim, Eun-Young
Publicado no Drug Des Devel Ther (2017)
“... and were also coadministered the same dose of both drugs given separately. The crossover study design...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
107
“... with renal insufficiency, a low dose (1.5 mg once daily) of fondaparinux or prophylactic LMWH subcutaneously...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
108
Por Kožíšek, Milan, Henke, Sandra, Šašková, Klára Grantz, Jacobs, Graeme Brendon, Schuch, Anita, Buchholz, Bernd, Müller, Viktor, Kräusslich, Hans-Georg, Řezáčová, Pavlína, Konvalinka, Jan, Bodem, Jochen
Publicado em 2012
“... of a patient-derived, multiresistant HIV-1 CRF02_AG recombinant strain with a highly mutated protease...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
109
Por Huang, Jie, Fu, Cheng-xiao, Yang, Xiao-yan, Cui, Chan, Yang, Shuang, Kuang, Yun, Guo, Cheng-xian, Hu, Pei, Pei, Qi, Yang, Guo-ping
Publicado no Drug Des Devel Ther (2018)
“... administered in single and multiple oral doses in Chinese subjects. SUBJECTS AND METHODS: Both the single...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
110
Por Yang, Jun, Yu, Ya-Li, Jin, Yu, Zhang, Ying, Zheng, Chang-Qing
Publicado no World J Gastroenterol (2016)
“...AIM: To summarize and compare the clinical characteristics of drug-induced liver injury (DILI...”Publicado no World J Gastroenterol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
111
“... assessment with different mammalian cell types. Despite their relative ease of performance, such assays lack...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
112
Por Gopal, Pooja, Yee, Michelle, Sarathy, Jickky, Low, Jian Liang, Sarathy, Jansy P., Kaya, Firat, Dartois, Véronique, Gengenbacher, Martin, Dick, Thomas
Publicado no ACS Infect Dis (2016)
“... distinct mechanisms of resistance to the drug. The emergence of resistance through the loss of a virulence...”Publicado no ACS Infect Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
113
Por Bozdogan, Bülent, Ednie, Lois, Credito, Kim, Kosowska, Klaudia, Appelbaum, Peter C.
Publicado em 2004
“.... Ten days of drug-free subculture caused the loss of vanA in two vancomycin-susceptible derivatives...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
114
Por Jung, Jin Ah, Lee, Soo-Yun, Kim, Jung-Ryul, Ko, Jae-Wook, Jang, Seong Bok, Nam, Su Youn, Huh, Wooseong
Publicado no Drug Des Devel Ther (2015)
“.../day), and both drugs concomitantly for 4 days in a randomized, open-label, multiple-dose, three...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
115
Por SreeHarsha, Nagaraja, Venugopala, Katharigatta N, Nair, Anroop B, Roopashree, Teeka S, Attimarad, Mahesh, Hiremath, Jagadeesh G, Al-Dhubiab, Bandar E, Ramnarayanan, Chandramouli, Shinu, Pottathil, Handral, Mukund, Haroun, Micheline, Tratrat, Christophe
Publicado no Drug Des Devel Ther (2019)
“... to improve individuals’ quality of life. Conventional dosage schemes used in public health to cure various...”Publicado no Drug Des Devel Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
116
“...1 The effects of some guanidine derivatives, (—)-N-(1-phenylethyl) guanidine (PEG), guanethidine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
117
Por Anastassopoulou, Cleo G, Marozsan, Andre J, Matet, Alexandre, Snyder, Amy D, Arts, Eric J, Kuhmann, Shawn E, Moore, John P
Publicado em 2007
“...; in the present study, fitness is a measure of how well strains of human immunodeficiency virus type 1 (HIV-1...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
118
Por Niki Alevra Sarika, Valéry L. Payen, Maximilien Fléron, Joachim Ravau, Davide Brusa, Mustapha Najimi, Edwin De Pauw, Gauthier Eppe, Gabriel Mazzucchelli, Etienne M. Sokal, Anne des Rieux, Adil El Taghdouini
Publicado em 2020-05-01
“... liver’s highly specialized parenchymal and non-parenchymal cell types importantly hampers...”Publicado em 2020-05-01
Obter o texto integral
Artigo
119
Por Lee, Jieon, Lee, Howard, Jang, Kyungho, Lim, Kyoung Soo, Shin, Dongseong, Yu, Kyung-Sang
Publicado em 2014
“..., their drug–drug interaction potential has not been investigated. This study compared the pharmacokinetic (PK...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
120
“... are the drug class of choice for overactive bladder symptoms. A combination of the two drug classes would be a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo